J. Lew

2.1k total citations
25 papers, 1.2k citations indexed

About

J. Lew is a scholar working on Infectious Diseases, Molecular Biology and Epidemiology. According to data from OpenAlex, J. Lew has authored 25 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Infectious Diseases, 11 papers in Molecular Biology and 5 papers in Epidemiology. Recurrent topics in J. Lew's work include SARS-CoV-2 and COVID-19 Research (11 papers), COVID-19 Clinical Research Studies (11 papers) and Tuberculosis Research and Epidemiology (4 papers). J. Lew is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (11 papers), COVID-19 Clinical Research Studies (11 papers) and Tuberculosis Research and Epidemiology (4 papers). J. Lew collaborates with scholars based in Canada, United States and United Kingdom. J. Lew's co-authors include Stewart T. Cole, Adamandia Kapopoulou, Louis Jones, Darryl Falzarano, Jason Kindrachuk, Noreen Rapin, Vikram Misra, Arinjay Banerjee, Magen E. Francis and Nicholas Dawe and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and PLoS ONE.

In The Last Decade

J. Lew

25 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Lew Canada 13 774 616 451 192 107 25 1.2k
Babak Javid China 19 675 0.9× 768 1.2× 515 1.1× 131 0.7× 272 2.5× 49 1.5k
Brad Efron United States 6 1.1k 1.4× 588 1.0× 720 1.6× 141 0.7× 120 1.1× 6 1.6k
Chao Wu China 23 581 0.8× 492 0.8× 333 0.7× 139 0.7× 285 2.7× 62 1.4k
Oksana Ocheretina United States 19 504 0.7× 354 0.6× 406 0.9× 116 0.6× 111 1.0× 40 964
Matthias I. Gröschel United Kingdom 15 722 0.9× 279 0.5× 518 1.1× 52 0.3× 264 2.5× 35 1.0k
Matthias Merker Germany 24 1.3k 1.6× 435 0.7× 1.2k 2.7× 155 0.8× 145 1.4× 80 1.9k
Dorothy Fallows United States 22 908 1.2× 373 0.6× 743 1.6× 52 0.3× 217 2.0× 36 1.3k
Jian Tang China 13 711 0.9× 310 0.5× 197 0.4× 142 0.7× 222 2.1× 30 1.3k
Ana Shulla United States 8 581 0.8× 314 0.5× 147 0.3× 118 0.6× 120 1.1× 8 1.0k
Yaqing He China 19 1.3k 1.7× 471 0.8× 316 0.7× 117 0.6× 180 1.7× 75 2.1k

Countries citing papers authored by J. Lew

Since Specialization
Citations

This map shows the geographic impact of J. Lew's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Lew with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Lew more than expected).

Fields of papers citing papers by J. Lew

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Lew. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Lew. The network helps show where J. Lew may publish in the future.

Co-authorship network of co-authors of J. Lew

This figure shows the co-authorship network connecting the top 25 collaborators of J. Lew. A scholar is included among the top collaborators of J. Lew based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Lew. J. Lew is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aulakh, Gurpreet Kaur, et al.. (2025). Recruitment of pulmonary intravascular macrophages in SARS-CoV-2 infected hamsters. Cell and Tissue Research. 400(1). 1–15. 1 indexed citations
2.
Lew, J., et al.. (2025). Combination therapy enhances the antiviral activity of IFN-λ against SARS-CoV-2 and MERS-CoV. Virus Research. 355. 199560–199560. 2 indexed citations
3.
Francis, Magen E., Rachelle Buchanan, Kerry J. Lavender, et al.. (2023). Previous infection with seasonal coronaviruses does not protect male Syrian hamsters from challenge with SARS-CoV-2. Nature Communications. 14(1). 5990–5990. 2 indexed citations
4.
Ndishimye, Pacifique, Rachelle Buchanan, Sabin Nsanzimana, et al.. (2023). Third COVID-19 vaccine dose boosts antibody function in Rwandans with high HIV viral load. iScience. 26(10). 107959–107959. 3 indexed citations
5.
Bhanumathy, Kalpana K., J. Lew, Anil Kumar, et al.. (2023). Generation of a SARS-CoV-2 Reverse Genetics System and Novel Human Lung Cell Lines That Exhibit High Virus-Induced Cytopathology. Viruses. 15(6). 1281–1281. 7 indexed citations
6.
Lew, J., et al.. (2022). SARS-CoV-2 Variant-Specific Infectivity and Immune Profiles Are Detectable in a Humanized Lung Mouse Model. Viruses. 14(10). 2272–2272. 4 indexed citations
7.
Scruten, Erin, Amanda Lang, J. Lew, et al.. (2022). High-resolution analysis of long-term serum antibodies in humans following convalescence of SARS-CoV-2 infection. Scientific Reports. 12(1). 9045–9045. 3 indexed citations
8.
Ostrov, David A., Andrew P. Bluhm, Kalpana K. Bhanumathy, et al.. (2021). Highly Specific Sigma Receptor Ligands Exhibit Anti-Viral Properties in SARS-CoV-2 Infected Cells. Pathogens. 10(11). 1514–1514. 10 indexed citations
9.
Francis, Magen E., Brian Richardson, Roger D. Pechous, et al.. (2021). Sex and age bias viral burden and interferon responses during SARS-CoV-2 infection in ferrets. Scientific Reports. 11(1). 14536–14536. 18 indexed citations
10.
Banerjee, Arinjay, Sonu Subudhi, Noreen Rapin, et al.. (2020). Selection of viral variants during persistent infection of insectivorous bat cells with Middle East respiratory syndrome coronavirus. Scientific Reports. 10(1). 7257–7257. 21 indexed citations
11.
Slayden, Richard A., Mary Jackson, Jeremy Zucker, et al.. (2013). Updating and curating metabolic pathways of TB. Tuberculosis. 93(1). 47–59. 18 indexed citations
12.
Lew, J., Chunhong Mao, Maulik Shukla, et al.. (2013). Database resources for the tuberculosis community. Tuberculosis. 93(1). 12–17. 26 indexed citations
13.
Brokx, S., Amy K. Wernimont, Aiping Dong, et al.. (2011). Characterization of 14-3-3 Proteins from Cryptosporidium parvum. PLoS ONE. 6(8). e14827–e14827. 25 indexed citations
14.
Lew, J., Adamandia Kapopoulou, Louis Jones, & Stewart T. Cole. (2010). TubercuList – 10 years after. Tuberculosis. 91(1). 1–7. 320 indexed citations
15.
Kapopoulou, Adamandia, J. Lew, & Stewart T. Cole. (2010). The MycoBrowser portal: A comprehensive and manually annotated resource for mycobacterial genomes. Tuberculosis. 91(1). 8–13. 328 indexed citations
16.
Artz, J.D., Amy K. Wernimont, James E. Dunford, et al.. (2010). Molecular Characterization of a Novel Geranylgeranyl Pyrophosphate Synthase from Plasmodium Parasites. Journal of Biological Chemistry. 286(5). 3315–3322. 49 indexed citations
17.
Savchenko, Alexei, Nevan J. Krogan, John Cort, et al.. (2005). The Shwachman-Bodian-Diamond Syndrome Protein Family Is Involved in RNA Metabolism. Journal of Biological Chemistry. 280(19). 19213–19220. 84 indexed citations
18.
Saridakis, V., Alexander F. Yakunin, Xiaohui Xu, et al.. (2004). The Structural Basis for Methylmalonic Aciduria. Journal of Biological Chemistry. 279(22). 23646–23653. 36 indexed citations
19.
Lew, J., et al.. (2004). CDKN1C mutation in Wiedemann–Beckwith syndrome patients reduces RNA splicing efficiency and identifies a splicing enhancer. American Journal of Medical Genetics Part A. 127A(3). 268–276. 10 indexed citations
20.
Du, Minjie, Linda G. Beatty, Wenjing Zhou, et al.. (2003). Insulator and silencer sequences in the imprinted region of human chromosome 11p15.5. Human Molecular Genetics. 12(15). 1927–1939. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026